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ABSTRACT 26 
Introduction: Exercise performed with blood flow restriction simultaneously enhances 27 
the acute responses to both myogenic and mitochondrial pathways with roles in training 28 
adaptation. We investigated isoform-specific gene expression of the peroxisome 29 
proliferator-activated receptor gamma (PPARG) coactivator 1 and selected target genes 30 
and proteins regulating skeletal muscle training adaptation. Methods: 9 healthy, 31 
untrained males participated in a randomized, counter-balanced, cross-over design in 32 
which each subject completed a bout of low-intensity endurance exercise performed 33 
with blood flow restriction (15 min cycling at 40% of VO2peak, BFR-EE), endurance 34 
exercise (30 min cycling at 70% of VO2peak, EE) or resistance exercise (4 x 10 35 
repetitions of leg press at 70% of 1-repetition maximum, RE) separated by at least one-36 
week recovery. A single resting muscle biopsy (vastus lateralis) was obtained two 37 
weeks before the first exercise trial (rest) and 3 h after each boat. Results: Total PGC-1α 38 
mRNA abundance, along with all four isoforms, increased above rest with EE only 39 
(P<0.05) being higher than BFR-EE (P<0.05).  PGC-1α1, 2 and 4 were higher after EE 40 
compared to RE (P<0.05). EE also increased VEGF, Hif-1α and MuRF-1 mRNA 41 
abundance above rest (P<0.05) while COXIV mRNA expression increased with EE 42 
compared to BFR-EE (P<0.05). Conclusion: The attenuated expression of all four PGC-43 
1α isoforms when endurance exercise is performed with blood flow restriction suggests 44 
this type of exercise provides an insufficient stimulus to activate the signaling pathways 45 
governing mitochondrial and angiogenesis responses observed with moderate- to high 46 
intensity endurance exercise.  47 
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Introduction 51 
 Skeletal muscle is a highly malleable tissue that can alter its phenotype 52 
according to the contractile stimulus imposed (39). For instance, moderate-intensity 53 
(i.e., <65% of peak oxygen uptake [VO2peak]) endurance exercise training enhances 54 
whole-body V̇O2peak (4), increases the maximal activities of oxidative enzymes, and 55 
shifts patterns of substrate selection from carbohydrate- to fat-based fuels (18). In 56 
contrast, strenuous (80% of one repetition maximum [1-RM]) resistance exercise has 57 
little or no effects on whole-body VO2peak and oxidative enzyme profiles (11) but 58 
increases myofibrillar protein accretion and muscle cross-sectional area (CSA) (30). 59 
 60 
While resistance and endurance exercise could be considered at opposite ends of 61 
the ‘adaptation continuum’ by virtue of their divergent biochemical and morphological 62 
phenotypes, blood flow restriction during low-intensity endurance exercise (BFR-EE) 63 
improves both VO2peak, muscle strength and CSA (1, 2). Abe and co-workers (1) 64 
reported increased isometric muscle strength, muscle CSA and VO2peak following 8 65 
weeks (24 training sessions) of low-intensity cycle exercise (15 min at 40% VO2peak) 66 
performed with BFR-EE compared to same exercise undertaken without BFR. While 67 
these adaptation responses are considerably lower in magnitude relative to conventional 68 
endurance and resistance training performed at higher intensities, the local hypoxia 69 
induced by BFR appears to induce an additive ‘metabolic stressor’ that perturbs cellular 70 
homeostasis (17) and concomitantly enhances both anabolic and oxidative adaptations. 71 
 72 
The cellular mechanisms mediating adaptation responses to exercise are 73 
complex involving the cross talk of several intracellular signaling systems that 74 
ultimately form the basis for specific phenotypic responses with divergent contractile 75 
modes (17). The transcriptional co-activator Peroxisome proliferator-activated receptor 76 
gamma (PPARG) coactivator 1 alpha (PGC-1α) is a ‘master regulator’ of many 77 
endurance exercise-induced adaptations by virtue of its central role in promoting 78 
mitochondrial biogenesis, angiogenesis, and inflammatory proteins (17). Transcription 79 
of the PGC-1α gene has been shown to be under the control of several promoter regions 80 
with activation of the alternative PGC-1α1 promoter resulting in the transcription of 81 
three additional isoforms: PGC-1α2, -α3 and-α4. Ruas and colleagues (32) recently 82 
demonstrated a preferential increase in the PGC1-α4 isoform following resistance 83 
exercise in human skeletal muscle. However, little is known about the regulation of the 84 
α2 and α3 isoforms and, to date, no studies have investigated the expression of all four 85 
PGC-1α isoforms to diverse contractile stimuli such as resistance and endurance 86 
exercise, or following BFR, in humans. Accordingly, the aim of the present study was 87 
to compare the acute molecular responses mediated by the different PGC-1α isoforms 88 
following low intensity endurance exercise (BFR-EE), resistance exercise (RE) and 89 
moderate endurance exercise (EE). As BFR-EE can promote both endurance capacity 90 
and muscle hypertrophy responses, we hypothesised EE and RE would selectively 91 
increase the expression of the PGC-1α1 and α4 isoforms, respectively. In contrast, we 92 
hypothesized that BFR-EE would upregulate a molecular signature involving the 93 
increase of both isoforms and their respective anabolic and mitochondrial gene targets. 94 
 95 
METHODS 96 
Subjects  97 
Nine untrained, healthy male subjects [age 22.4 ± 3.0 yr, body mass (BM) 73.5 ± 98 
9.7 kg, height 1.79 ± 0.05 m, maximal oxygen uptake test (VO2peak) 36.8 ± 4.8 mLlkg-99 
1·min-1, leg press one repetition maximum (1-RM) 266 ± 66 kg; values are mean ± SD] 100 
voluntarily participated in this study. The experimental procedures and possible risks 101 
associated with the study were explained to all subjects, who provided written informed 102 
consent before participation. The study was approved by the local University’s Ethics 103 
Committee and conducted in conformity with the policy statement regarding the use of 104 
human subjects according to the latest revision of the Declaration of Helsinki. 105 
 106 
Experimental Design  107 
The study employed a randomized counter-balanced, cross-over design in which 108 
each subject completed a bout of either resistance exercise (RE), endurance cycling 109 
exercise (EE) or low-intensity cycling exercise combined with blood flow restriction 110 
(BFR-EE). Two weeks prior to the first exercise session, a resting muscle biopsy was 111 
obtained before participants underwent VO2peak and one-repetition maximum (1-RM) 112 
testing, and exercise familiarization. Exercise trials were separated by a one-week 113 
recovery period during which time subjects maintained their habitual diet and physical 114 
activity patterns.  115 
 116 
Preliminary Testing 117 
VO2peak. Participants performed a maximum graded exercise test on a cycle ergometer 118 
with electromagnetic braking (Quinton modelo: Corival 400, Lode BV, Groningen, 119 
Netherlands) based on a protocol used in previously published paper that investigated 120 
BFR-EE (1). Briefly, after resting on the bike for 5 min, participants commenced the 121 
incremental test protocol. Briefly, subjects commenced cycling at an initial load of 50 122 
W for 1 min and the workload was increased by 15 W/min until a workload of 200 W 123 
was reached, after which further increases were 10 W/min increments. The test 124 
continued until voluntary exhaustion, defined by two of the three following criteria: 125 
VO2peak plateau (< 2.1 mL.kg-1.min-1 of variation), > 1.10 respiratory exchange ratio, 126 
and/or heart rate higher than 90% of maximum estimated from age (19). Gas exchange 127 
data were collected continuously using an automated breath-by-breath metabolic system 128 
(CPX, Medical Graphics, St. Paul, Minnesota, USA) and the highest oxygen 129 
consumption value was defined as the peak oxygen consumption (VO2peak) over any 30 130 
sec period. To confirm the appropriateness of this protocol for this study we performed 131 
a pilot study to verify repeatability in VO2peak measures and observed a strong 132 
repeatability in VO2peak (3.0%), power (1.9%), respiratory exchange ratio (RER) (5.6%), 133 
and time to exhaustion (1.6%) measures. 134 
 135 
Maximal Strength  136 
The one-repetition maximum (1-RM) test was performed on a leg press machine 137 
(45º leg press, G3-PL70; Matrix, São Paulo, Brazil) as previously described (8). Briefly, 138 
participants performed a 5 min warm-up on a cycle ergometer riding at 25 W. 139 
Participants then undertook 1 x 10 repetitions at 50% of their estimated 1-RM, followed 140 
by 1 x 3 repetitions at 70% of the estimated 1-RM with 1-min rest between sets. 141 
Participants then performed a series of single repetitions until the maximum load (1-142 
RM) lifted was established with fully eccentric-concentric movement with 90º range of 143 
motion. Repetitions were separated by a 3-min recovery and were used to establish the 144 
maximum load/weight that could be moved through the full range of motion once, but 145 
not a second time. 146 
 147 
Diet/Exercise Control 148 
Before each experimental trial (described subsequently), subjects were instructed 149 
to refrain from exercise training and vigorous physical activity, and alcohol and caffeine 150 
consumption for a minimum of 48 h. Subjects were provided with standardized 151 
prepacked meals that consisted of 3 g carbohydrate/kg body mass (BM), 0.5 g 152 
protein/kg BM, and 0.3 g fat/kg body mass consumed as the final caloric intake the 153 
evening before reporting for an experimental trial. 154 
 155 
Experimental Testing Sessions  156 
On the morning of an experimental trial, subjects reported to the laboratory after a ~10-157 
h overnight fast. After resting in the supine position for ~15 min and under local 158 
anaesthesia (2–3 mL of 1% Xylocaine), a resting biopsy was obtained from the vastus 159 
lateralis using a 5-mm Bergstrom needle modified with suction (7). Approximately 100 160 
mg of muscle was removed, dissected free from blood and connective tissue and snap 161 
frozen in liquid nitrogen before being stored at – 80°C until subsequent analyses. Due to 162 
ethical constraints regarding the total number of muscle biopsies allowed, this single 163 
resting biopsy was used as a basal control for all subsequent exercise trials. Two weeks 164 
later participants returned to the laboratory having (after the same pre-trial diet and 165 
exercise control) to undertake the first of three randomly assigned exercise sessions 166 
(described below). Each exercise trial was separated by a one week wash out. Following 167 
the completion of each exercise session, subjects rested for 180 min after which time a 168 
muscle biopsy was obtained. Subsequent incisions were performed 3 cm proximal to 169 
each other. Blood samples were collected before each exercise session and immediately, 170 
1, 2 hr and 3 hr post exercise. Blood samples were immediately placed in microtubes 171 
containing 1% sodium fluoride and then centrifuged at 3000 rpm for 5 min to separate 172 
the plasma before being aliquoted and frozen in liquid nitrogen and stored at -80°C. 173 
 174 
Resistance Exercise (RE) 175 
After a standardized warm-up on a cycle ergometer consisting of 5 min light 176 
cycling at 25 W, subjects performed 4 sets of 10 repetitions leg press exercise (45° leg 177 
press machine; G3-PL70; Matrix) at 70% of 1-RM. Each set was separated by a 1 min 178 
recovery period during which time subjects remained seated on the leg press machine. 179 
Complete concentric/eccentric movements were performed with 90° of range of motion 180 
and strong verbal encouragement was provided during each set. The volume and 181 
intensity of this session was based on the recommendations of American College Sports 182 
Medicine (ACSM) (3). All participants completed every repetition from each respective 183 
set. 184 
 185 
Endurance Exercise (EE) 186 
Following a standardized warm up (described previously), subjects performed 187 
30 min of continuous cycling at a power output that elicited ~at 70% of individual 188 
VO2peak. Subjects were fan-cooled and provided visual feedback for pedal frequency, 189 
power output, and elapsed time were provided to subjects. The volume and intensity of 190 
this session were based on the recommendations of ACSM (4). All participants 191 
completed the full 30 min session. 192 
 193 
Low Intensity Blood Flow Restriction (BFR-EE) 194 
Subjects performed 15 min continuous cycling with a cuff strapped over the 195 
thigh at a power output that elicited at 40% of VO2peak, as previously reported (1). An 196 
18-cm wide cuff was placed on the proximal portion of the thigh (inguinal fold region) 197 
over the tibial artery  and once in position, was inflated until an absence of auditory 198 
blood pulse detected through auscultation with a vascular Doppler probe (DV-600; 199 
Marted, São Paulo, Brazil). Pressure was then slowly released until the first arterial 200 
pulse was detected which was considered the systolic pressure at the tibial artery. Cuff 201 
pressure was set at 80% of the maximum tibial arterial pressure and the cuff was 202 
inflated through-out the entire exercise session (22). 203 
 204 
Analytical Procedures 205 
Blood Lactate  206 
Plasma lactate concentration was measured on a spectrophotometer (ELx800, 207 
Biotek, Winooski, USA) using a commercial kit (Biotecnica, Varginha, Brazil) 208 
according to the manufacturer’s protocol. 209 
 210 
RNA Extraction and Quantification 211 
 Approximately 20 mg of skeletal muscle was homogenized in TRIzol with 212 
chloroform added to form an aqueous RNA phase. This RNA phase was then 213 
precipitated by mixing with ice-cold isopropanol alcohol and the resulting pellet was 214 
washed and re-suspended in 40 µl of RNase-free water. Extracted RNA was quantified 215 
using a NanoDrop 1000 spectrophotometer (Nanodrop Technologies, Wilmington, 216 
USA) by measuring absorbance at 260 nm and 280 nm.  217 
 218 
Reverse Transcription  219 
First-strand complementary DNA (cDNA) synthesis was performed using 220 
commercially available TaqMan Reverse Transcription Reagents (Invitrogen, 221 
Melbourne, Australia) in a final reaction volume of 20 µL. All RNA and negative 222 
control samples were reverse transcribed to cDNA in a single run from the same reverse 223 
transcription master mix. Serial dilutions of a template human skeletal muscle RNA 224 
(AMBION; Cat No AM7982) was included to ensure efficiency of reverse transcription 225 
and for calculation of a standard curve for real-time quantitative polymerase chain 226 
reaction (RT-PCR). 227 
 228 
Real-Time PCR 229 
Quantification (in duplicate) of mRNA was performed using a CFX96 Touch™ 230 
Real-Time PCR Detection System (Bio Rad, California, USA). Taqman-FAM-labelled 231 
primer/probes for MuRF-1 (Cat No. Hs00822397_m1), COXIV (Cat No. 232 
Hs00971639_m1), IL-6 (Cat No. Hs00985639_m1), PGC-1α (Cat No. 233 
Hs01016719_m1), HIF-1α (Cat No. Hs00153153_m1), Myostatin (Hs00976237_m1), 234 
IGF-1 (Hs01547656_m1) and VEGF (Cat No. Hs00900055_m1) were used in a final 235 
reaction  volume of 20 µL. PCR treatments were 2 min at 50 ºC for UNG activation, 10 236 
min at 95 ºC then 40 cycles of 95 ºC for 15 s and 60 ºC for 60s. Glyceraldehyde-3-237 
phosphate dehydrogenase (GAPDH) (Cat No Hs02758991_g1) was used as a 238 
housekeeping gene and was stably expressed between exercise interventions (data not 239 
shown). The relative amounts of mRNAs were calculated using the relative 240 
quantification (∆∆CT) method (24). All Taqman-based PCR experiments were 241 
performed in the Centre for Exercise and Nutrition laboratory at the Australian Catholic 242 
University. 243 
 244 
Quantification of PGC-1α isoforms 245 
RNA was extracted from a separate piece of snap frozen muscle (~20 mg) using TRIzol 246 
(Invitrogen) and purified using QIAGEN RNeasy mini-columns. Reverse transcription 247 
was performed using a High Capacity cDNA Reverse Transcription kit (Applied Bio-248 
systems). Real-Time Quantitative PCR was carried out in a SYBR Green ER PCR 249 
Master Mix (Invitrogen)/ 384-well format using an ABI PRISM 7900HT (Applied 250 
Biosystems). Relative mRNA levels were calculated using the comparative CT method 251 
and normalized to cyclophilin mRNA. Primer sequences are as follows: Cyclophilin 252 
(forward: GGAGATGGCACAGGAGGAA; reverse: GCCCGTAGTGC TTCAGTTT), 253 
PGC1α1 (forward: ATG GAG TGA CAT CGA GTG TGC T; reverse: GAG TCC ACC 254 
CAG AAA GCT GT), PGC1α2 (forward: AGT CCA CCC AGA AAG CTG TCT; 255 
reverse: ATG AAT GAC ACA CAT GTT GGG), PGC1α3 (forward: CTG CAC CTA 256 
GGA GGC TTT ATG C; reverse: CAA TCC ACC CAG AAA GCT GTC T), and 257 
PGC1α4 (forward: TCA CAC CAA ACC CAC AGA GA; reverse: CTG GAA GAT 258 
ATG GCA CAT). All SYBR Green-based PCR experiments were performed in the 259 
Department of Cell Biology laboratory at the Dana-Farber Cancer Institute, Harvard 260 
Medical School (USA). 261 
 262 
Western Blots 263 
Approximately 30 mg of muscle was homogenized in buffer containing 50 mM 264 
Tris·HCl pH 7.5, 1 mM EDTA, 1 mM EGTA, 10% glycerol, 1% Triton X-100, 50 mM 265 
NaF, 5 mM sodium pyrophosphate, 1 mM DTT, 10% μg/ml trypsin inhibitor, 2 μg/ml 266 
aprotinin, 1mM benzamidine, and 1 mM PMSF. After determination of protein 267 
concentration (Pierce, Rockford, IL), lysate was resuspended in Laemmli sample buffer. 268 
Lysate was then re-suspended in Laemmli sample buffer with 40 µg of protein loaded 269 
onto 4–20% Mini-PROTEAN TGX Stain-Free™ Gels (Bio Rad, California, USA). Post 270 
electrophoresis gels were activated according to the manufacturer’s details (Chemidoc, 271 
Bio-Rad, Gladesville, Australia) and then transferred to polyvinylidine fluoride (PVDF) 272 
membranes. After transfer, a Stain-Free image of the PVDF membranes for total protein 273 
normalization was obtained before membranes were rinsed briefly in distilled water and 274 
blocked with 5% non-fat milk, washed with 10 mM of Tris–HCl, 100 mM of NaCl, and 275 
0.02% Tween 20, and incubated with primary antibody (1:1000) overnight at 4 °C. 276 
Membranes were incubated with secondary antibody (1:2,000), and proteins were 277 
detected via chemiluminescence (Amersham Biosciences, Buckinghamshire, UK; 278 
Pierce Biotechnology, Rockford, IL) and quantified by densitometry. All sample time 279 
points for each subject were run on the same gel. Polyclonal anti-phospho-mTORSer2448 280 
(no. 2971), -p70 S6KThr389 (no. 9206), - adenosine monophosphate kinase (AMPK)Thr172 281 
(no. 2531), eukaryotic translation initiation factor 4E-binding protein 1 (4E-BP1) 4E-282 
BP1Thr37/46 (no. 9459), eEF2 eukaryotic translation elongation factor 2 (eEF2) eEF2Thr56 283 
(no. 2331) and p53Ser15 (no. 9284) were purchased from Cell Signaling Technology 284 
(Danvers, MA, USA). Volume density of each target protein band was normalized to 285 
the total protein loaded into each lane using stain-free technology (15) with data 286 
expressed in arbitrary units. Due to low sample availability, phosphorylated proteins 287 
were unable to be normalized to their respective total protein content and were therefore 288 
also normalized to stain-free protein levels. 289 
 290 
Statistical analysis  291 
Statistical analysis was performed using SAS version 9.3 for Windows (SAS 292 
Institute Inc., Cary, NC, USA). Data normality and variance equality were assessed 293 
through the Shapiro-Wilk and Levene tests. One-way ANOVA with repeated measures 294 
(factor: condition) was performed for gene and protein expression analyses. A mixed 295 
model ANOVA, assuming group and time as fixed factors and subjects as a random 296 
factor, was performed for blood lactate data. Tukey post hoc analysis was used for 297 
multiple comparison purposes when significant F-values were found. The significance 298 
level was set at P ≤ 0.05. Data are presented as Mean ± Standard Deviation (SD). 299 
 300 
Results 301 
mRNA expression 302 
Total PGC1-α and isoforms 303 
Total PGC-1α mRNA (Figure 1A) increased with EE above rest (P<0.0001), RE 304 
(P=0.0013) and BFR-EE (P>0.0001). There was a significant increase in PGC-1α1 305 
mRNA with EE above rest (P=0.0450), RE (P=0.0069) and BFR-EE (P=0.0349) 306 
(Figure 1B). There was also a significant increase in PGC-1α2 mRNA (Figure 1C) with 307 
EE above rest (P<0.0001), RE (P=0.0003) and BFR-EE (P<0.0001). PGC-1α3 mRNA 308 
(Figure 1D) increased with EE above rest (P=0.0389). There was also increases PGC-309 
1α4 mRNA (Figure 1E) with EE above rest (P=0.0035), RE (P=0.0469) and BFR-EE 310 
(P=0.0140). 311 
 312 
**Figure 1 here** 313 
 314 
VEGF, COXIV, HIF-1a 315 
There was a significant increase in VEGF mRNA (Figure 2A) with EE above 316 
rest (P=0.0180) and RE (P=0.0069). COXIV mRNA expression increased with EE 317 
above BFR-EE (P=0.0550) (Figure 2B). There was a significant increase in HIF-1a 318 
abundance with EE above Rest (P= 0.0530) (Figure 2C). 319 
 320 
**Figure 2 here** 321 
 322 
IL-6 – IGF-1 - Myostatin - MurRF1  323 
IL-6, IGF-1 and Myostatin mRNA expression were unchanged post-exercise 324 
(Figure 3 A, B, C).  There was a post-exercise increase in MuRF1 mRNA abundance 325 
with EE above Rest (P=0.0003), RE (P=0.0256) and BFR-EE (P=0.0007) (Figure 3D). 326 
 327 
**Figure 3 here** 328 
 329 
Cell Signaling 330 
mTOR -p70S6K -4E-BP1 -eEF2  331 
 There were no changes in mTORSer2448, p70S6KThr389, 4E-BP1Thr37/46or eEF2Thr56 332 
phosphorylation post-exercise or between exercise groups (Figure 4). 333 
 334 
**Figure 4 here** 335 
 336 
AMPK -p53 337 
AMPKThr156and p53Ser15 phosphorylation were unchanged post-exercise (Figure 338 
5). 339 
 340 
**Figure 5 here** 341 
 342 
Plasma lactate concentration 343 
 Lactate concentration increased above rest immediately post-exercise for all 344 
interventions (P<.0001 for all comparisons; Table 1). Lactate concentration remained 345 
elevated at 1 h, 2 h and 3 h post-exercise for EE and RE, and 1 h and 2 h for BFR-EE 346 
(P<.0001 for all comparisons).  347 
 348 
**Table 1 here** 349 
 350 
Discussion 351 
Low intensity (<50% of VO2peak) endurance training with blood flow restriction 352 
has been shown to concomitantly promote isometric muscle strength, muscle CSA and 353 
VO2peak (1, 2). While these enhanced adaptation responses are considerably lower in 354 
magnitude compared to conventional resistance or endurance exercise performed 355 
without any blood flow restriction, the underlying molecular mechanisms mediating 356 
these responses remain largely undefined. For the first time we report that low intensity 357 
endurance cycling exercise performed with blood flow restriction failed to increase 358 
PGC-1α expression to that commonly observed with ‘conventional’ endurance exercise. 359 
Moreover, we show isoform-specific post-exercise increases in the α4 isoform along 360 
with Hif-1α and VEGF mRNA expression following higher intensity endurance 361 
exercise without blood flow restriction. Taken collectively, our novel findings suggest 362 
that cycle exercise undertaken with blood flow restriction is unable to provoke the 363 
perturbations to cellular homeostasis necessary to induce activation of the cell signaling 364 
events regulating mitochondrial biogenesis and angiogenesis that take place with higher 365 
intensity endurance exercise without blood flow restriction. 366 
 367 
A growing body of evidence suggests that exercise undertaken with blood flow 368 
restriction can enhance exercise adaptation. A recent meta-analysis reported both low 369 
load/intensity resistance (20–30% 1 RM) and aerobic walking exercise performed with 370 
blood flow restriction can induce increases in muscle strength and hypertrophy, 371 
although with smaller gains compared to high intensity resistance exercise alone (35). 372 
However, little is known about the molecular mechanisms mediating these responses 373 
when low intensity endurance exercise is undertaken with blood flow restriction. As 374 
such, we compared the expression of key gene and protein targets implicated in a range 375 
of exercise adaptation responses such as hypertrophy, mitochondrial biogenesis, muscle 376 
proteolysis, substrate metabolism and angiogenesis between BFR-EE, and conventional 377 
bouts of RE and EE. We particularly focused on the four different full-length PGC-1α 378 
isoforms putatively implicated in anabolic and mitochondrial-related adaptation 379 
responses.  380 
 381 
In agreement with previous studies (5, 23, 29), we observed significant increases in total 382 
PGC-1α mRNA following continuous endurance exercise performed at 70% of VO2peak. 383 
This increase in PGC-1α mRNA was concomitant with greater abundance of VEGF, a 384 
target of PGC-1α (37). However, in contrast to our original hypothesis, this response 385 
was absent following a bout of low-intensity endurance exercise (40% VO2peak) 386 
performed with blood flow restriction. In an attempt to identify possible mechanisms 387 
responsible for this attenuated PGC-1α response, we investigated IL-6 expression to 388 
determine whether an increase in the muscular inflammatory program was implicated in 389 
the blunted response. This hypothesis was based on previous data showing an inverse 390 
relationship between skeletal muscle PGC-1α and IL-6 expression (16). However, IL-6 391 
mRNA expression post-exercise was unchanged in all exercise groups suggesting any 392 
acute increase in muscle inflammation caused by BFR-EE was not responsible for the 393 
reduced PGC-1α1 expression observed. We also investigated other cellular markers 394 
implicated in exercise adaptation responses that can regulate PGC-1α expression. 395 
AMPK is an intracellular ‘fuel gauge’ that can phosphorylate PGC-1α and increase its 396 
transcriptional activity (36) while the apoptogenic protein p53 has emerged as another 397 
signaling regulator of skeletal muscle exercise-induced mitochondrial biogenesis and 398 
substrate metabolism that can translocate to the nucleus upon activation and induce 399 
PGC-1α expression (17). Phosphorylation of either of these protein targets was 400 
unaltered post-exercise suggesting other molecular markers and/or physiological 401 
mechanisms may be responsible for the upregulation of PGC-1α with high intensity 402 
endurance exercise. One plausible explanation for these discrepant findings may be the 403 
level of glycogen utilization between exercise sessions in our untrained subjects. We 404 
(10) and others (6, 31) have shown greater post-exercise PGC-1α expression with low- 405 
compared to normal or high glycogen concentration and although we did not measure 406 
muscle glycogen use in the current study due to limited muscle tissue availability, the 407 
longer duration and higher intensity exercise bout is likely to have induced greater 408 
glycogen depletion compared to the endurance exercise session performed with blood 409 
flow restriction.  410 
 411 
Another possible explanation for the discrepancy in PGC-1α1 expression between the 412 
two endurance-based exercise bouts is the large differences in estimated energy 413 
expenditure. Exercise energy expenditure after BFR-EE was ~4 fold less compared to 414 
the EE protocol with total energy expenditure positively associated with PGC-1α 415 
expression (r=0.73, P=0.039). Increased PGC-1α mRNA expression has been observed 416 
after 30 min running compared to bouts of 20 and 10 min (37). Thus, total exercise-417 
induced energy expenditure may be an overriding determinant of PGC-1α expression 418 
responses post-exercise.  419 
 420 
Low intensity endurance exercise with BFR was also unable to induce the expression of 421 
PGC-1α4 compared to higher intensity endurance exercise without blood flow 422 
restriction. The PGC-1α4 isoform has been proposed to promote muscle hypertrophy by 423 
inducing IGF-1 expression and reducing the expression of myostatin, a negative 424 
regulator of muscle growth (32). The increase in PGC-1α4 mRNA expression with EE 425 
in the current study was mirrored by a small, non-significant, increase and decrease in 426 
IGF1 and myostatin expression, respectively. Ruas and colleagues were the first to 427 
show a selective increase in PGC-1α4 expression (concomitant with decreased 428 
myostatin abundance) with resistance compared to endurance exercise in human skeletal 429 
muscle (32). However, this expression pattern was observed following 8 weeks whole-430 
body resistance training. Thus, a limitation of our study is that we only incorporated a 431 
single bout of isolated leg press suggesting longer training programs/ exercise stimulus 432 
may be required to induce this selective PGC-1α4 response. Nonetheless, another recent 433 
publication reported increased truncated and non-truncated PGC-1a transcripts from 434 
both alternative and proximal promoter sites 2 hours following an acute bout of 435 
resistance exercise that incorporated the same volume and intensity as our study (40). 436 
This indicates the resistance exercise bout performed in our study was likely sufficient 437 
to induce the appropriate signal to increase the expression of this isoform however 438 
potential differences in post-exercise biopsy timing between this study and ours (2 h vs. 439 
3 h) may explain why we did not observe this increase with resistance exercise. 440 
 441 
Increased PGC-1α4 and VEGF expression has also been reported in primary myotubes 442 
treated under hypoxic conditions suggesting low oxygen conditions to be favorable for 443 
the activation of this isoform (38). In the current study, the transcription factor Hif-1α, a 444 
key regulator of angiogenesis in situations of hypoxia (34), was unchanged following 445 
BFR-EE, while RE and EE induced 2-fold higher post-exercise changes in lactate 446 
compared to BFR-EE. While it is possible a greater metabolic and hypoxic stimulus 447 
may be required to increase PGC-1α4 signaling, others have reported unchanged blood 448 
lactate following aerobic-based exercise with blood flow restriction (26). Moreover, the 449 
same occlusion protocol (15 min cycle at 40% VO2peak) has been shown to improve 450 
muscle volume and VO2peak, during a chronic training intervention (1). Thus, it is 451 
possible chronic exposure to this occlusion stimulus may be required to elicit increases 452 
in PGC-1α4 expression. As this is the first study to investigate changes in Hif-1α 453 
following endurance cycling exercise with BFR it is difficult to compare our results to 454 
those of previous investigations incorporating resistance exercise and BFR. However, 455 
we speculate that when performed with blood flow restriction, the lower contractile 456 
intensity associated with ‘conventional’ endurance compared to resistance (or sprint) 457 
exercise, provides adequate blood flow to the exercising musculature and adjoining 458 
capillary beds in order to prevent tissue de-oxygenation. Further studies comparing 459 
different low intensity endurance exercise protocols with resistance exercise that 460 
incorporate blood flow restriction are required to corroborate this hypothesis. 461 
 462 
Another novel finding from the current study was the post-exercise increases in the 463 
PGC-1α2 and 3 isoforms. Similar to the α1 and α4 isoforms, both PGC-1α2 and α3 464 
increased above rest with higher intensity endurance exercise and were significantly 465 
elevated compared to resistance exercise. Both isoforms are expressed in skeletal 466 
muscle and brown adipose tissue although little is known about the regulatory targets of 467 
these isoforms and their capacity to mediate exercise adaptation responses (27). Based 468 
on the elevated response following endurance compared to resistance exercise, we 469 
propose these isoforms to mediate physiological processes related to mitochondrial 470 
biogenesis and substrate metabolism.    471 
 472 
Considering low load endurance exercise with BFR can increase muscle strength and 473 
hypertrophy (35), we also investigated markers of translation initiation, elongation and 474 
muscle proteolysis. Previous studies have reported increases in mTOR and p70S6K 475 
phosphorylation that have formed the basis for enhanced rates of muscle protein 476 
synthesis following resistance exercise with blood flow restriction (13, 14).  477 
Nonetheless, the phosphorylation status of these proteins as well as 4E-BP1 and eEF2 478 
were unchanged 3 h post-exercise in the current study. This is in agreement with the 479 
results of Ozaki and colleagues (28) who observed no changes in Akt, mTOR or 480 
p70S6K phosphorylation following 20 min treadmill walking performed with blood 481 
flow restriction despite a higher intensity exercise bout (55% VO2peak) compared to our 482 
protocol. While our study design was somewhat limited by only having the single post-483 
exercise biopsy (9), this sampling time-point was specifically chosen based on previous 484 
studies showing significant, and in some cases maximal, increases in PGC-1α mRNA 485 
expression in response to an exercise challenge (5, 23). Future studies investigating 486 
endurance exercise undertaken with BFR-EE should include a time-course of signaling 487 
responses in order to determine the optimal ‘window’ for muscle sampling in 488 
subsequent investigations.  489 
 490 
Several other factors including the width and pressure of cuff used during BFR must 491 
also be considered. Previous studies have reported smaller increases in muscle CSA 492 
when lower body resistance training is undertaken with BFR (compared to no BFR) at 493 
the site of the cuff (12, 20). While this indicates a narrow cuff may be advantageous for 494 
promoting anabolic adaptation responses due to compressing less muscle tissue, a recent 495 
study comparing the effects of a wide versus narrow cuff reported similar increases in 496 
maximum strength and muscle cross sectional area following 12 weeks of unilateral 497 
elbow flexion performed at 20% of 1RM (21). Also, a recent study showed that there 498 
was no difference in either muscle strength or hypertrophy between different occlusion 499 
pressures (25). Thus, the use of a wider cuff, as used in our protocol, appears unlikely to 500 
attenuate chronic muscle anabolic responses. Regardless, these studies are currently 501 
only limited to BFR with resistance exercise. Future studies comparing these parameters 502 
when endurance exercise is performed with BFR are required. Finally, MuRF-1 mRNA 503 
expression increased post endurance exercise which resulted in a higher expression 504 
above endurance exercise with BFR and resistance exercise. MuRF-1 mediates the 505 
ubiquitin proteasome system by ‘labelling’ cleaved myofibril segments for degradation 506 
(33). It is unclear whether this increase in expression with high intensity endurance 507 
exercise represents general tissue remodeling, particularly considering our participants 508 
were untrained and the unaccustomed contractile stimulus, or a greater induction of 509 
protein degradation.  510 
 511 
In summary, this is the first study to investigate the molecular mechanisms mediating 512 
muscle adaptation responses to low intensity endurance cycling exercise with blood 513 
flow restriction. The attenuated expression of all four PGC-1α isoforms when endurance 514 
exercise is performed with blood flow restriction suggests this type of exercise is unable 515 
to induce the appropriate metabolic perturbation capable of activating the cell signaling 516 
machinery responsible for mitochondrial biogenesis and angiogenesis responses with 517 
moderate-to-high intensity endurance exercise. Longer training programs incorporating 518 
endurance exercise with BFR that correlate measurements of these molecular markers 519 
with functional adaptation responses such as changes in VO2peak and cycle time to 520 
fatigue will yield important information to the efficacy of this training method to 521 
enhance training adaptation and subsequently improve health outcomes in populations 522 
that may be unable to perform, prolonged exercise.  523 
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 670 
Figure 1. (A) Total Peroxisome proliferator-activated receptor-γ coactivator 1α (PGC-671 
1α), (B) Peroxisome proliferator-activated receptor-γ coactivator 1α (PGC-1α1), (C) 672 
Peroxisome proliferator-activated receptor-γ coactivator 1α2 (PGC-1α2), (D) 673 
Peroxisome proliferator-activated receptor-γ coactivator 1α3 (PGC-1α3) and (E) 674 
Peroxisome proliferator-activated receptor-γ coactivator 1α4 (PGC-1α4) mRNA 675 
abundance at rest and 3 h  post-exercise recovery following  endurance exercise (EE), 676 
resistance exercise (RE) or low-intensity associated with blood flow restriction (BFR-677 
EE). Values are expressed relative to GAPDH and presented in arbitrary units (mean ± 678 
SD, n=9). a= Significant different from Rest (P≤ 0.05); b= Significant different from 679 
HI-RT (P≤ 0.05); c= Significant different from BFR-EE (P≤ 0.05).   680 
 681 
 682 
 683 
 684 
 685 
 686 
 687 
 688 
 689 
 690 
 691 
 692 
 693 
 694 
 695 
Figure 2. (A) Vascular endothelial growth factor (VEGF), (B) Cytochrome c oxidase 696 
subunit 4 isoform 1 (COXIV) and (C) hypoxia-inducible factor-1 alpha (HIF-1α) 697 
mRNA abundance at rest and 3 h  post-exercise recovery following  endurance exercise 698 
(EE), resistance exercise (RE) or low-intensity associated with blood flow restriction 699 
(BFR-EE). Values are expressed relative to GAPDH and presented in arbitrary units 700 
(mean ± SD, n=9). a= Significant different from Rest (P≤ 0.05); b= Significant different 701 
from HI-RT (P≤ 0.05); c= Significant different from BFR-EE (P≤ 0.05).  702 
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Figure 3. (A) Interleukin 6 (IL-6), (B) Insulin-like growth factor 1(IGF-1), (C) Muscle 721 
RING finger 1 (MURF1) and (D) Myostatin mRNA abundance at rest and 3 h post-722 
exercise recovery following endurance exercise (EE), resistance exercise (RE) or low-723 
intensity associated with blood flow restriction (BFR-EE). Values are expressed relative 724 
to GAPDH and presented in arbitrary units (mean ± SD, n=9). a= Significant different 725 
from Rest (P≤ 0.05); b= Significant different from HI-RT (P≤ 0.05); c= Significant 726 
different from BFR-EE (P≤ 0.05).    727 
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Figure 4. (A) Mechanistic target of rapamycin (mTOR)Ser2448 (B) p70S6KThr389 (C) 740 
eukaryotic translation initiation factor 4E-binding protein 1 (4E-BP1)Thr37/46 eukaryotic 741 
elongation factor 2 (eEF2)Thr56 phosphorylation in skeletal  muscle at rest and after 3 h  742 
post-exercise recovery following endurance exercise (EE), resistance exercise (RE) or 743 
low-intensity associated with blood flow restriction (BFR-EE). Values are normalized 744 
to total protein loaded determined by stain free technology in arbitrary units (mean ± 745 
SD, n=9).  746 
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Figure 5. (A) Adenosine Monophosphate-Activated Protein (AMPK)Thr172 and (B) 758 
p53Ser15 phosphorylation in skeletal muscle at rest and after 3 h post-exercise recovery 759 
following endurance exercise (EE), resistance exercise (RE) or low-intensity associated 760 
with blood flow restriction (BFR-EE). Values are normalized to total protein loaded 761 
determined by stain free technology in arbitrary units (mean ± SD, n=9). 762 
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